Executive Order 14357
Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
This executive order reduces the additional ad valorem duty on Chinese imports from 20% to 10%, effective November 10, 2025, following commitments by China to take measures against synthetic opioid trafficking. The order modifies the Harmonized Tariff Schedule of the United States and establishes ongoing monitoring of China's compliance.